首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1642869

體外診斷 (IVD)：技術與全球市場

In Vitro Diagnostics: Technologies and Global Markets

出版日期: 2025年01月22日 | 出版商:

BCC Research | 英文 159 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球體外診斷 (IVD) 市場規模預計將從 2024 年的947 億美元增至 2029 年底的 1,419 億美元，預測期內的複合年成長率為 8.4%。

免疫化學 IVD 市場預計將從 2024 年的 328 億美元成長到 2029年終的430 億美元，預測期內的複合年成長率為 5.5%。 POC IVD 檢測市場預計將從 2024 年的 232 億美元成長到 2029年終的384 億美元，複合年成長率為 10.6%。

本報告調查了全球體外診斷（IVD）市場，並提供了市場的全面概述、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展的趨勢、市場規模的趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業的概況。

概述
市場促進因素
老年人口不斷增加：對診斷程序的依賴
人工智慧與IVD的整合
慢性病流行
提高就地檢驗(POCT) 的質量
市場限制
與技術產品包裝相關的挑戰
運輸成本增加和服務問題
實驗室助理缺乏操作實驗室設備和耗材的技能
市場機會
居家照護檢測設備的興起
POCT 設備需求
對人工智慧和物聯網的需求不斷成長

第4章新興科技與發展

IVD 市場的新興技術
AI
舊 IVD 技術已改進
液態生物檢體
自動化體外診斷設備
IVD 的新發展
FDA核准
個人化醫療需求日益成長
實驗室自動化和數位健康平台
IVD 裝置可移植性選項
癌症診斷居家護理套件
FDA核准的IVD 裝置：支援人工智慧

第5章市場區隔分析

細分市場
依技術進行市場分析
免疫化學
POC 測試
血
分子診斷
組織診斷
臨床微生物學
市場分析：按應用
糖尿病
腎
血糖值評估與監測 (BGEM)
瘤
心臟病
感染疾病
其他
最終用戶的市場分析
診斷實驗室
醫院和診所
點檢中心
其他
地理分佈
市場分析：按地區
北美洲
歐洲
亞太地區
拉丁美洲
中東和非洲

第6章競爭訊息

全球企業排名分析
中國主要IVD企業概況
協議、合作與夥伴關係
IVD 公司和Start-Ups

7. 體外診斷 (IVD) 產業的永續性：ESG 視角

ESG 在 IVD 製造業的重要性
IVD 產業的 ESG 實踐
環境績效
社會績效
管治績效
企業在 ESG 發展中的作用
ESG風險評估
BCC 的看法

第 8 章附錄

調查方法
參考
公司簡介
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
JSR CORP.
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: HLC186D

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

The immunochemistry IVD market is expected to grow from $32.8 billion in 2024 and is projected to reach $43.0 billion by the end of 2029, at a CAGR of 5.5% during the forecast period of 2024 to 2029.

The POC testing IVD market is expected to grow from $23.2 billion in 2024 and is projected to reach $38.4 billion by the end of 2029, at a CAGR of 10.6% during the forecast period of 2024 to 2029.

Report Scope

This report covers the in vitro diagnostic (IVD) technologies as well as in vitro diagnostic devices used in hospitals and point-of-care (POC) facilities to diagnose diseases. It also details the current and future market potential of in vitro diagnostic technology and includes an analysis of this market's competitive environment. The report covers market drivers, restraints, opportunities, product approvals, regulatory scenario assessments and emerging technologies. It features market projections and estimates of the market shares of key players through 2029.

In this analysis, the in vitro diagnostics market is segmented based on technologies, applications, end users and region. Based on technologies, the market is segmented into the following categories: hematology, immunochemistry, molecular diagnostics, POC testing, clinical microbiology and tissue diagnostics. Based on applications, the in vitro diagnostics market is segmented into these categories: diabetes, nephrology, blood glucose evaluation and monitoring (BGEM), oncology, cardiology, infectious diseases and other applications. The market is segmented based on end users into diagnostic laboratories, hospitals and clinics, point-of-care centers, and other end users.

The global in vitro diagnostics market has been segmented by the following geographical regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report features detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia and New Zealand (ANZ), Argentina, Brazil, South Africa, Mexico and the GCC countries. Market analysis data is provided for 2023, which serves as the base year, and estimates are given for 2024 and forecast values through 2029.

Report Includes

41 data tables and 54 additional tables
Analysis of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimates of the size of the market for in vitro diagnostics (IVD) technologies, revenues, and market shares by technology, product, application, end user and region
Assessment of market dynamics such as drivers, restraints and opportunities
Discussion of how the rise in the number of respiratory infections, hospital acquired infections (HAIs), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
Discussion of IVD for neglected infectious diseases, chemistry-based portable analysis and microfluidic platform-based POC tests
A discussion on ESG challenges and practices in the industry
Assessment of the competitive landscape, including the market shares of key companies, their product portfolios and financial overviews
Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments and product launches
Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Abbott, Sysmex Corp., Danaher, BD, and Siemens Healthineers AG

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market and Technology Background

Introduction
In vitro Diagnostics Technology
Overview
Classification of In Vitro Diagnostic Elements
Importance of In Vitro Diagnostics Technologies and Quality Control
Difference Between In Vitro and In Vivo Diagnostics
Regulations in the IVD Industry
Regulation of IVD Products in Different Countries

Chapter 3 Market Dynamics

Overview
Market Drivers
Rise in Population of Older Adults: Dependence on Diagnosis Procedures
Integration of Artificial Intelligence in Vitro Diagnostics
Rising Prevalence of Chronic Diseases
Improving the Quality of Point-of-Care Testing (POCT)
Market Restraints
Challenges Associated with Technologies Product Packaging
Increases in Shipping Costs or Service Issues
Laboratory Assistant's Inability to Handle Laboratory Equipment and Consumables
Market Opportunities
Rise in Home Care Testing Devices
Demand for Point-of-Care (POC) Testing Units
Growing Demand for AI and the Internet of Things

Chapter 4 Emerging Technologies and Developments

Emerging Technologies in the IVD Market
Artificial Intelligence
Modified Old IVD Techniques
Liquid Biopsy
Automated In Vitro Diagnostic Devices
Emerging Developments in In Vitro Diagnostics
FDA Approval
Rise in Demand for Personalized Medicine
Lab Automation and Digital Health Platform
Portability Option in IVD Devices
Home Care Kits for Cancer Diagnosis
FDA Approved In Vitro Diagnostic Devices: AI Enabled

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Technology
Immunochemistry
POC Testing
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Microbiology
Market Analysis by Application
Diabetes
Nephrology
Blood Glucose Evaluation and Monitoring (BGEM)
Oncology
Cardiology
Infectious Diseases
Other Applications
Market Analysis by End User
Diagnostic Laboratory
Hospitals and Clinics
Point-of-Care (POC) Centers
Other End Users
Geographical Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Chapter 6 Competitive Intelligence

Introduction
Global Analysis of Company Market Ranking
Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
Agreements, Collaborations and Partnerships
bioMerieux Agreements
Siemens Healthineers and Sysmex Enter into a Global Agreement
Roche Enters into Agreement with Path AI
Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
In Vitro Diagnostics Companies and Start-Ups in 2021-2023
Diagopreutic Private Limited
Diatherax
IPLEXMED
Magnify Bioscience Inc.

Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective

Importance of ESG in In Vitro Diagnostics Manufacturing Industry
ESG Practices in the In Vitro Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
Company Role in ESG Development
ESG Risk Ratings
BCC Research Viewpoint

Chapter 8 Appendix

Research Methodology
References
Company Profiles
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
JSR CORP.
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 1 : Approved FDA In Vitro Diagnostics Devices, 2021-2024
Table 2 : Differences Between In Vitro and In Vivo Diagnostics
Table 3 : FDA Approval of Artificial Intelligence and Machine Learning-Enabled Medical Devices, 2024
Table 4 : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 5 : Global Market for In Vitro Diagnostics in Immunochemistry, by Region, Through 2029
Table 6 : Global Market for In Vitro Diagnostics in POC Testing, by Region, Through 2029
Table 7 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
Table 8 : Global Market for In Vitro Diagnostics in Hematology, by Region, Through 2029
Table 9 : Global Market for In Vitro Diagnostics in Molecular Diagnostics, by Region, Through 2029
Table 10 : Global Market for In Vitro Diagnostics in Tissue Diagnostics, by Region, Through 2029
Table 11 : Global Market for In Vitro Diagnostics in Clinical Microbiology, by Region, Through 2029
Table 12 : Global Market for In Vitro Diagnostics, by Application, Through 2029
Table 13 : Global Market for Diabetes in In Vitro Diagnostics, by Region, Through 2029
Table 14 : Global Market for Nephrology in In Vitro Diagnostics, by Region, Through 2029
Table 15 : Global Market for BGEM in In Vitro Diagnostics, by Region, Through 2029
Table 16 : Global Market for Oncology in In Vitro Diagnostics, by Region, Through 2029
Table 17 : Global Market for Cardiology in In Vitro Diagnostics, by Region, Through 2029
Table 18 : Global Market for Infectious Diseases in In Vitro Diagnostics, by Region, Through 2029
Table 19 : Global Market for Other Applications in In Vitro Diagnostics, by Region, Through 2029
Table 20 : Global Market for In Vitro Diagnostics, by End User, Through 2029
Table 21 : Global Market for In Vitro Diagnostics for Diagnostic Laboratory, by Region, Through 2029
Table 22 : Global Market for In Vitro Diagnostics for Hospitals and Clinics, by Region, Through 2029
Table 23 : Global Market for In Vitro Diagnostics for Point-of-Care Centers, by Region, Through 2029
Table 24 : Global Market for In Vitro Diagnostics for Other End Users, by Region, Through 2029
Table 25 : Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 26 : North American Market for In Vitro Diagnostics, by Country, Through 2029
Table 27 : European Market for In Vitro Diagnostics, by Country, Through 2029
Table 28 : Asia-Pacific Market for In Vitro Diagnostics, by Country, Through 2029
Table 29 : Latin American Market for In Vitro Diagnostics, by Sub-Region, Through 2029
Table 30 : Total Imports of Medical Equipment into Brazil, 2021 and 2022
Table 31 : Middle Eastern and African Market for In Vitro Diagnostics Technology, by Sub-Region, Through 2029
Table 32 : bioMerieux Agreements
Table 33 : ESG Practices: Environmental Performance
Table 34 : ESG Practices: Social Performance
Table 35 : ESG Practices: Governance Performance
Table 36 : Creating an Attractive Workplace: Social Performance
Table 37 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
Table 38 : Abbott: Company Snapshot
Table 39 : Abbott: Financial Performance, FY 2022 and 2023
Table 40 : Abbott: Product Portfolio
Table 41 : Abbott: News/Key Developments, 2022-2024
Table 42 : BD: Company Snapshot
Table 43 : BD: Financial Performance, FY 2022 and 2023
Table 44 : BD: Product Portfolio
Table 45 : BD: News/Key Developments, 2022-2024
Table 46 : BIOMERIEUX: Company Snapshot
Table 47 : BIOMERIEUX: Financial Performance, FY 2022 and 2023
Table 48 : BIOMERIEUX: Product Portfolio
Table 49 : BIOMERIEUX: News/Key Developments, 2023 and 2024
Table 50 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 51 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 52 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 53 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 54 : Bio-Techne: Company Snapshot
Table 55 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 56 : Bio-Techne: Product Portfolio
Table 57 : Bio-Techne: News/Key Developments, 2022 and 2023
Table 58 : Bruker: Company Snapshot
Table 59 : Bruker: Financial Performance, FY 2022 and 2023
Table 60 : Bruker: Product Portfolio
Table 61 : Bruker: News/Key Developments, 2021-2024
Table 62 : Danaher Corp.: Company Snapshot
Table 63 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64 : Danaher Corp.: Product Portfolio
Table 65 : Danaher Corp.: News/Key Developments, 2021-2023
Table 66 : EKF Diagnostics Holdings plc.: Company Snapshot
Table 67 : EKF Diagnostics Holdings plc.: Financial Performance, FY 2022 and 2023
Table 68 : EKF Diagnostics Holdings plc.: Product Portfolio
Table 69 : EKF Diagnostics Holdings plc.: News/Key Developments, 2022-2024
Table 70 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 71 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 72 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 73 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 74 : Hologic Inc.: Company Snapshot
Table 75 : Hologic Inc.: Financial Performance, FY 2022 and 2023
Table 76 : Hologic Inc.: Product Portfolio
Table 77 : Hologic Inc.: News/Key Developments, 2022-2024
Table 78 : JSR Corp.: Company Snapshot
Table 79 : JSR Corp.: Financial Performance, FY 2022 and 2023
Table 80 : JSR Corp.: Product Portfolio
Table 81 : JSR Corp.: News/Key Developments, 2024
Table 82 : QuidelOrtho Corp.: Company Snapshot
Table 83 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 84 : QuidelOrtho Corp.: Product Portfolio
Table 85 : QuidelOrtho Corp.: News/Key Developments, 2021-2024
Table 86 : Siemens Healthineers AG: Company Snapshot
Table 87 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 88 : Siemens Healthineers AG: Product Portfolio
Table 89 : Siemens Healthineers AG: News/Key Developments, 2021-2024
Table 90 : Sysmex Corp.: Company Snapshot
Table 91 : Sysmex Corp.: Financial Performance, FY 2022 and 2023
Table 92 : Sysmex Corp.: Product Portfolio
Table 93 : Sysmex Corp.: News/Key Developments, 2022 and 2023
Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 97 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023

List of Figures

Summary Figure : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 1 : Snapshot of Market Dynamics
Figure 2 : Older Adults Using Technology to Manage Chronic Health Issues in the U.S., by Age Group, 2024
Figure 3 : Percentage of People Aged 50+ Using Digital Services in the U.S., 2024
Figure 4 : Breakdown of Global Elderly Population (Aged 65+ Years), by Select Countries, 2022
Figure 5 : Emerging AI Applications in In Vitro Diagnostics
Figure 6 : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 7 : Global Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 8 : Snapshot of IVD Tests in Oncology
Figure 9 : Global Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 10 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 11 : North American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 12 : North American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 13 : North American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 14 : North American Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 15 : European Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 16 : European Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 17 : European Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 18 : European Market Shares of In Vitro Diagnostics, by Sub-Region , 2023
Figure 19 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 20 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 21 : Asia-Pacific Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 22 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 23 : Latin American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 24 : Latin American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 25 : Latin American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 26 : Latin American Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 27 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 28 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 29 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 30 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 31 : Rankings of Leading Companies in Global In Vitro Diagnostics Market, 2023
Figure 32 : Snapshot: Key ESG Trends in the In Vitro Diagnostics Industry
Figure 33 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 34 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 35 : BD: Revenue Shares, by Business Unit, FY 2023
Figure 36 : BD: Revenue Shares, by Country/Region, FY 2023
Figure 37 : BIOMERIEUX: Revenue Shares, by Business Unit, FY 2023
Figure 38 : BIOMERIEUX: Revenue Shares, by Country/Region, FY 2023
Figure 39 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 41 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023
Figure 42 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023
Figure 43 : Bruker: Revenue Shares, by Business Unit, FY 2023
Figure 44 : Bruker: Revenue Shares, by Country/Region, FY 2023
Figure 45 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 46 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 47 : EKF Diagnostics Holdings plc.: Revenue Shares, by Business Unit, FY 2023
Figure 48 : EKF Diagnostics Holdings plc.: Revenue Shares, by Country/Region, FY 2023
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 51 : Hologic Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 52 : Hologic Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 53 : JSR Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 54 : JSR Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 55 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 56 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 57 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
Figure 58 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023
Figure 59 : Sysmex Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 60 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 61 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 62 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023